|
1）Freed CR, Greene PE, Breeze RE, et al. Transplantation of embryonic dopamine neurons for severe Parkinsonʼs disease. N Engl J Med. 2001; 344: 710-9
|
|
|
|
2）Olanow CW, Goetz CG, Kordower JH, et al. A double-blind controlled trial of bilateral fetal nigral transplantation in Parkinsonʼs disease. Ann Neurol. 2003; 54: 403-14
|
|
|
|
|
|
3）Mendez I, Viñuela A, Astradsson A, et al. Dopamine neurons implanted into people with Parkinsonʼs disease survive without pathology for 14 years. Nat Med. 2008; 14: 507-9
|
|
|
|
|
|
4）Kordower JH, Chu Y, Hauser RA, et al. Lewy body-like pathology in long-term embryonic nigral transplants in Parkinsonʼs disease. Nat Med. 2008; 14: 504-6
|
|
|
|
|
|
5）Li JY, Englund E, Holton JL, et al. Lewy bodies in grafted neurons in subjects with Parkinsonʼs disease suggest host-to-graft disease propagation. Nat Med. 2008; 14: 501-3
|
|
|
|
|
|
6）Politis M, Wu K, Loane C, et al. Serotonergic neurons mediate dyskinesia side effects in Parkinsonʼs patients with neural transplants. Sci Transl Med. 2010; 2: 38ra46
|
|
|
|
|
|
7）Barker RA, Barrett J, Mason SL, et al. Fetal dopaminergic transplantation trials and the future of neural grafting in parkinsonʼs disease. Lancet Neurol. 2013; 12: 84-91
|
|
|
|
|
|
8）Okita K, Matsumura Y, Sato Y, et al. A more efficient method to generate integration-free human iPS cells. Nat Methods. 2011; 8: 409-12
|
|
|
|
|
|
9）Nakagawa M, Takizawa N, Narita M, et al. Promotion of direct reprogramming by transformation-deficient myc. Proc Natl Acad Sci U S A. 2010; 107: 14152-7
|
|
|
|
|
|
10）Maekawa M, Yamaguchi K, Nakamura T, et al. Direct reprogramming of somatic cells is promoted by maternal transcription factor Glis1. Nature. 2011; 474: 225-9
|
|
|
|
|
|
11）Placzek M, Briscoe J. The floor plate: Multiple cells, multiple signals. Nat Rev Neurosci. 2005; 6: 230-40
|
|
|
|
|
|
12）Chambers SM, Fasano CA, Papapetrou EP, et al. Highly efficient neural conversion of human ES and iPS cells by dual inhibition of SMAD signaling. Nat Biotechnol. 2009; 27: 275-80
|
|
|
|
|
|
13）Morizane A, Doi D, Kikuchi T, et al. Small-molecule inhibitors of bone morphogenic protein and activin/nodal signals promote highly efficient neural induction from human pluripotent stem cells. J Neurosci Res. 2011; 89: 117-26
|
|
|
|
|
|
14）Kriks S, Shim J-W, Piao J, et al. Dopamine neurons derived from human ES cells efficiently engraft in animal models of Parkinsonʼs disease. Nature. 2011; 480: 547-51
|
|
|
|
|
|
15）Kirkeby A, Grealish S, Wolf D, et al. Generation of regionally specified neural progenitors and functional neurons from human embryonic stem cells under defined conditions. Cell Rep. 2012; 1: 703-14
|
|
|
|
|
|
16）Hargus G, Cooper O, Deleidi M, et al. Differentiated Parkinson patient-derived induced pluripotent stem cells grow in the adult rodent brain and reduce motor asymmetry in Parkinsonian rats. Proc Natl Acad Sci U S A. 2010; 107: 15921-6
|
|
|
|
|
|
17）Luk KC, Kehm VM, Zhang B, et al. Intracerebral inoculation of pathological α-synuclein initiates a rapidly progressive neurodegenerative α-synuc-leinopathy in mice. J Exp Med. 2012; 209: 975-86
|
|
|
|
|
|
18）Nguyen HN, Byers B, Cord B, et al. LRRK2 mutant iPSC-derived DA neurons demonstrate increased susceptibility to oxidative stress. Cell Stem Cell. 2011; 8: 267-80
|
|
|
|
|
|
19）Doi D, Morizane A, Kikuchi T, et al. Prolonged maturation culture favors a reduction in the tumorigenicity and the dopaminergic function of human ESC-derived neural cells in a primate model of Parkinsonʼs disease. Stem Cells. 2012; 30: 935-45
|
|
|
|
|
|
20）Miyazaki T, Futaki S, Suemori H, et al. Laminin E8 fragments support efficient adhesion and expansion of dissociated human pluripotent stem cells. Nat Commun. 2012; 3: 1236
|
|
|
|
|
|
21）Brederlau A, Correia AS, Anisimov SV, et al. Transplantation of human embryonic stem cell-derived cells to a rat model of Parkinsonʼs disease: Effect of in vitro differentiation on graft survival and teratoma formation. Stem Cells. 2006; 24: 1433-40
|
|
|
|
|
|
22）Roy NS, Cleren C, Singh SK, et al. Functional engraftment of human ES cell-derived dopaminergic neurons enriched by coculture with telomerase-immortalized midbrain astrocytes. Nat Med. 2006; 12: 1259-68
|
|
|
|
|
|
23）Fukuda H, Takahashi J, Watanabe K, et al. Fluorescence-activated cell sorting-based purification of embryonic stem cell-derived neural precursors averts tumor formation after transplantation. Stem Cells. 2006; 24: 763-71
|
|
|
|
|
|
24）Chung S, Shin BS, Hedlund E, et al. Genetic selection of sox1gfp-expressing neural precursors removes residual tumorigenic pluripotent stem cells and attenuates tumor formation after transplantation. J Neurochem. 2006; 97: 1467-80
|
|
|
|
|
|
25）Chung S, Moon JI, Leung A, et al. ES cell-derived renewable and functional midbrain dopaminergic progenitors. Proc Natl Acad Sci U S A. 2011; 108: 9703-8
|
|
|
|
|
|
26）Caiazzo M, DellʼAnno MT, Dvoretskova E, et al. Direct generation of functional dopaminergic neurons from mouse and human fibroblasts. Nature. 2011; 476: 224-7
|
|
|
|
|